PMCTPharmaCountry
    Home

Analysis

In-depth analysis of pharmaceutical markets, supply chains, technology and regulation

#4615 ×

Analysis
Sep 21, 2026•1 min read
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.